PGEN

Precigen Inc

7.03

Sep 03 • 4:30 AM ET +0.02 (0.29%)

Healthcare Biotechnology USA Mid NASD

Peers: BEAM NTLA CRSP KYMR CRNX EDIT INCY RYTM KRYS BMRN

| Held by: XBI VTI IWM VXF IWO FYC IBB GRNJ VTWO SCHA

Index	RUT
Market Cap	2.52B
Enterprise Value	2.58B
Income	-336.70M
Sales	85.72M
Book/sh	0.12
Cash/sh	0.11
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	160
IPO	Aug 08, 2013

P/E	-
Forward P/E	10.29
PEG	-
P/S	29.36
P/B	57.76
P/C	65.87
P/FCF	-
EV/EBITDA	-
EV/Sales	30.06
Quick Ratio	3.89
Current Ratio	4.58
Debt/Eq	2.26
LT Debt/Eq	2.23
Option/Short	Yes / Yes

EPS (ttm)	-1.10
EPS next Y	0.68
EPS next Q	0.05
EPS this Y	110.22%
EPS next Y	388.09%
EPS next 5Y	-
EPS past 3/5Y	-60.61% -6.02%
Sales past 3/5Y	-28.87% -37.70%
EPS Y/Y TTM	-154.83%
Sales Y/Y TTM	1875.05%
EPS Q/Q	153.95%
Sales Q/Q	6322.66%
Earnings	Aug 04 AMC
EPS/Sales Surpr.	513.22% 96.47%

Insider Own	54.16%
Insider Trans	-3.05%
Inst Own	39.73%
Inst Trans	2.62%
ROA	-115.88%
ROE	-837.08%
ROIC	-111.95%
Gross Margin	89.19%
Oper. Margin	-46.08%
Profit Margin	-392.81%
SMA20	0.81%
SMA50	13.92%
SMA200	51.75%
Trades

Shs Outstand	358.01M
Shs Float	164.12M
Short Float	25.74%
Short Ratio	8.04
Short Interest	42.24M
52W High	7.72 -8.88%
52W Low	2.99 135.12%
Volatility	4.43% 5.88%
ATR (14)	0.36
RSI (14)	56.97
Beta	0.95
Rel Volume	0.00
Avg Volume	5.25M
Volume	169

Perf Week	-2.23%
Perf Month	2.03%
Perf Quarter	82.12%
Perf Half Y	108.61%
Perf YTD	68.18%
Perf Year	48.00%
Perf 3Y	288.40%
Perf 5Y	14.50%
Perf 10Y	-71.98%
Recom	1.67
Target Price	14.50
Prev Close	7.01
Price	7.03
Change %	0.29%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-15-25	Upgrade	JP Morgan	Underweight → Neutral
Mar-22-24	Downgrade	JP Morgan	Neutral → Underweight
May-23-23	Initiated	JP Morgan	Neutral
Nov-18-22	Initiated	Cantor Fitzgerald	Overweight	$7
Feb-25-21	Initiated	Stifel	Buy	$13
Feb-22-21	Initiated	Wells Fargo	Overweight	$14
Feb-18-21	Initiated	B. Riley Securities	Buy	$10
May-08-20	Initiated	H.C. Wainwright	Buy	$5

Aug-25-26 07:00AM	Precigen's Strong Second Quarter Signals Significant Growth, Validates AdenoVerse Platform; PRGN-2009 Advances in HPV-Driven Cancers (ACCESSWIRE)
Aug-05-26 08:30AM	Precigen, Inc. Q2 2026 Earnings Call Summary (Moby) +5.51%
01:04AM	Precigen Inc (PGEN) (Q2 2026) Earnings Call Highlights: Revenue Surges 145% and Net Profit Achieved (GuruFocus.com)
Aug-04-26 04:01PM	Precigen Reports Second Quarter 2026 Financial Results Highlighted by Accelerating PAPZIMEOS Revenue Growth (PR Newswire)
Jul-21-26 08:00AM	Precigen to Announce Second Quarter 2026 Financial Results and Provide Business Updates on August 4 (PR Newswire) +8.28%
06:40AM	Loading…
Jun-15-26 06:40AM	Precigen Gains Advantage as PAPZIMEOS Granted Orphan Drug Exclusivity by FDA; Long-Term Data From Clinical Study Encouraging (ACCESSWIRE) +7.87%
Jun-11-26 08:00AM	Precigen and the Recurrent Respiratory Papillomatosis Foundation Recognize International RRP Awareness Day by Elevating Patient and Community Voices (PR Newswire) +16.45%
May-30-26 02:30PM	Precigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Exclusivity, Demonstrating Complete Responses Beyond 4 Years (PR Newswire)
May-27-26 07:00AM	Precigen Receives Orphan Drug Exclusivity for PAPZIMEOS (zopapogene imadenovec-drba) in the United States (PR Newswire)
May-26-26 08:05AM	Precigen to Participate in Fireside Chats with J.P. Morgan and at the Goldman Sachs 47th Annual Global Healthcare Conference (PR Newswire)
May-14-26 08:30AM	Precigen, Inc. Q1 2026 Earnings Call Summary (Moby) +10.84%
01:02AM	Precigen Inc (PGEN) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid Operational ... (GuruFocus.com)
May-13-26 04:05PM	Precigen Reports First Quarter 2026 Financial Results and Business Updates (PR Newswire)
May-07-26 04:05PM	Precigen to Announce First Quarter 2026 Financial Results and Provide Business Updates on May 13 (PR Newswire) -5.68%
Apr-07-26 07:00AM	Precigen Reports 'Robust Uptake' of New Drug for Rare Respiratory Disease; First Quarter Revenue Expected to Top $18 Million (ACCESSWIRE)
08:30AM	Loading…
Mar-30-26 08:30AM	Precigen to Participate in a Fireside Chat with H.C. Wainwright on March 31 (PR Newswire) -11.44%
Mar-25-26 11:02PM	Precigen Inc (PGEN) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Expansion ... (GuruFocus.com) +25.48%
08:21PM	Precigen, Inc. Q4 2025 Earnings Call Summary (Moby)
04:05PM	Precigen Reports Full Year 2025 Financial Results and Business Updates (PR Newswire)
Mar-11-26 04:05PM	Precigen to Announce Full Year 2025 Financial Results and Provide Business Updates on March 25 (PR Newswire)
Mar-05-26 08:50AM	CorMedix (CRMD) Lags Q4 Earnings Estimates (Zacks) -5.07%
08:40AM	Precigen (PGEN) Surged Following the Early Approval of Papziemos (Insider Monkey)
Feb-13-26 07:14AM	Precigen, Inc. (PGEN) Builds Commercial Stage With Global Regulatory Support (Insider Monkey)
Jan-20-26 08:05AM	New Expert Consensus Published in The Laryngoscope Recommends PAPZIMEOS (zopapogene imadenovec) as the New Standard of Care First-Line Treatment for Adults with Recurrent Respiratory Papillomatosis (PR Newswire)
Jan-12-26 08:00AM	Precigen Showcases Rapid Commercialization Momentum and Growing Market Adoption of First-and-Only FDA-Approved Therapy for RRP at the 44th Annual J.P. Morgan Healthcare Conference (PR Newswire) -9.91%
Jan-05-26 04:05PM	Precigen to Present at the 44th Annual J.P. Morgan Healthcare Conference (PR Newswire) +8.85%
Nov-14-25 12:01AM	Precigen Inc (PGEN) Q3 2025 Earnings Call Highlights: FDA Approval and U.S. ... (GuruFocus.com) +25.65%
Nov-13-25 04:05PM	Precigen Reports Third Quarter 2025 Financial Results and Business Updates (PR Newswire)
Nov-06-25 04:30PM	Precigen to Announce Third Quarter 2025 Financial Results and Provide Business Updates on November 13 (PR Newswire)
Oct-26-25 06:05AM	Precigen Reports Positive Long-Term Follow-Up Data for FDA-Approved RRP Therapy, PAPZIMEOS (Insider Monkey)
07:00AM	Loading…
Oct-13-25 07:00AM	Precigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS, the First and Only FDA-approved Therapy for Adults with Recurrent Respiratory Papillomatosis (PR Newswire)
Sep-23-25 07:23PM	Precigen, Inc. (PGEN) Secures $125M to Accelerate PAPZIMEOS Commercialization (Insider Monkey)
Sep-20-25 02:43AM	Precigen, Inc. (PGEN) Bolsters Financial Standing to Enhance PAPZIMEOS Commercialization (Insider Monkey)
Sep-15-25 08:17AM	Precigen Signs a Credit Facility Agreement Worth $125 Million to Support PAPZIMEOS (Insider Monkey) -5.28%
Sep-12-25 03:41AM	4 years from clinic to approval Precigens unprecedented FDA nod and what comes next (Pharma Voice) -8.45%
Sep-11-25 03:31AM	Precigen's (PGEN) Papzimeos Push Sparks Multibagger Ascent, Boosted by Analyst Optimism (Insider Monkey)
Sep-07-25 08:23AM	These 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street Analysts (Motley Fool)
Sep-03-25 07:00AM	Precigen Announces Up to $125 Million Non-Dilutive Financing (PR Newswire)
Sep-02-25 12:57AM	Cantor Fitzgerald Reaffirms Overweight Rating on Precigen (PGEN) (Insider Monkey) +5.54%
Aug-28-25 10:00AM	INO Stock Soars as FDA Backs Rolling BLA for Rare Lung Disease Drug (Zacks)
Aug-26-25 08:39AM	Citizens JMP Raises PT on Precigen from $6 to $8, Keeps Outperform Rating (Insider Monkey) +7.04%
Aug-25-25 11:56PM	H.C. Wainwright Remains Bullish on Precigen (PGEN) (Insider Monkey)
11:04AM	PGEN Stock Surges 144% in August on FDA Nod for Rare Lung Disease Drug (Zacks)
10:30AM	BC-Most Active Stocks (Associated Press Finance)
08:05AM	Precigen to Participate in Upcoming Virtual Fireside Chats Hosted by Cantor and H.C. Wainwright (PR Newswire)
Aug-20-25 12:22AM	Precigen (PGEN) Secures FDA Approval for Papillomatosis Treatment (Insider Monkey)
Aug-18-25 10:30AM	BC-Most Active Stocks (Associated Press Finance)
07:42AM	FDA approves Papzimeos as first therapy for HPV-caused airway disease (Pharmaceutical Technology)
Aug-15-25 10:45AM	Hope Realized: FDA Approves Papzimeos for Adults with Recurrent Respiratory Papillomatosis (RRP) (Business Wire) +58.92%
10:30AM	BC-Most Active Stocks (Associated Press Finance)
07:20AM	Precigen wins immunotherapy approval; Pfizer sickle cell drug fails trial (BioPharma Dive)
07:00AM	Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis (PR Newswire)
May-14-25 04:05PM	Precigen Reports First Quarter 2025 Financial Results and Business Updates (PR Newswire) -5.19%
Apr-22-25 12:00PM	Patient Capital Management Q1 2025 Investment Review (Seeking Alpha) +11.68%
Apr-16-25 08:05AM	Precigen and Recurrent Respiratory Papillomatosis Foundation to Host the 2025 International RRP Awareness Day on June 11th (PR Newswire)
Mar-27-25 10:19AM	Is Precigen (PGEN) The Hot Biotech Stock Under $5? (InsiderMonkey)
Mar-21-25 06:23PM	Precigen Inc (PGEN) Q4 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Mar-19-25 07:47PM	Precigen, Inc. (PGEN) Q4 2024 Earnings Call Transcript (SeekingAlpha) +7.19%
06:25PM	Precigen, Inc. (PGEN) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Precigen Reports Full Year 2024 Financial Results and Business Updates (PR Newswire)
Mar-13-25 08:05AM	Precigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th (PR Newswire)
Mar-01-25 05:27PM	Why Precigen, Inc. (PGEN) is Skyrocketing So Far in 2025 (Insider Monkey)
Feb-25-25 08:05AM	FDA Grants Priority Review to Precigen's BLA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis with PDUFA Target Action Date Set for August 27, 2025 (PR Newswire)
Jan-13-25 07:00AM	Precigen to Present Plans for Realizing Commercial Vision for PRGN-2012 at the 43rd Annual J.P. Morgan Healthcare Conference (PR Newswire) -8.94%
Jan-09-25 08:30AM	Precigen to Present at the 43rd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-30-24 07:00AM	Precigen Completes Submission of BLA with Request for Priority Review to the FDA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (PR Newswire) +28.47%
Dec-27-24 09:00AM	Precigen Announces $79.0 Million Private Placement Offering of Convertible Preferred Stock (PR Newswire)
Nov-14-24 04:30PM	Precigen Reports Third Quarter 2024 Financial Results and Business Updates (PR Newswire) -7.11%
Nov-12-24 04:05PM	Precigen to Participate in the Stifel 2024 Healthcare Conference (PR Newswire) -5.04%
Sep-16-24 04:30PM	Precigen to Participate in the 2024 Cantor Global Healthcare Conference (PR Newswire)
Aug-14-24 04:05PM	Precigen Reports Second Quarter and First Half 2024 Financial Results and Business Updates (PR Newswire)
01:54PM	Hedge Fund and Insider Trading News: Nelson Peltz, Jana Partners, Whitebox Advisors, Caxton Associates LP, Altium Capital, Soros Fund Management, Elliott Investment Management, Balyasny Asset Management, Precigen Inc (PGEN), Vulcan Materials Company (VMC), and More (Insider Monkey)
Aug-09-24 08:00AM	Precigen to Announce Second Quarter and First Half 2024 Financial Results on August 14th (PR Newswire) -13.39%
Aug-07-24 09:30PM	Precigen Announces Pricing of $30.0 Million Public Offering of Common Stock (PR Newswire) -12.59% +7.63%
Aug-06-24 04:04PM	Precigen Announces Proposed $30 Million Public Offering of Common Stock (PR Newswire)
04:01PM	Precigen Strategically Prioritizes Portfolio to Focus on First Potential Gene Therapy Launch (PR Newswire)
Jul-23-24 08:01AM	Precigen Appoints Phil Tennant as Chief Commercial Officer to Spearhead First Potential Gene Therapy Launch (PR Newswire)
Jun-03-24 09:30AM	Precigen Announces Groundbreaking Pivotal Study Data for PRGN-2012 in Patients with Recurrent Respiratory Papillomatosis in Which More than Half of Patients Achieved Complete Response (PR Newswire) +11.43%
May-23-24 05:00PM	Precigen to Host a Webcast on June 3rd to Detail Pivotal Study Results of PRGN-2012 in Recurrent Respiratory Papillomatosis Presented at the 2024 ASCO Annual Meeting (PR Newswire)
May-14-24 05:20PM	Precigen, Inc. (PGEN) Reports Q1 Loss, Misses Revenue Estimates (Zacks) +5.11%
04:05PM	Precigen Reports First Quarter 2024 Financial Results and Business Updates (PR Newswire)
08:21AM	Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-08-24 04:05PM	Precigen to Announce First Quarter 2024 Financial Results on May 14th and Host a Conference Call on June 3rd following the Late-breaking Oral Presentation for PRGN-2012 at the 2024 ASCO Annual Meeting (PR Newswire)
Apr-24-24 10:20AM	Precigen to Present Late-breaking Abstract for Pivotal Phase 2 Study Data for PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Patients with Recurrent Respiratory Papillomatosis at the 2024 ASCO Annual Meeting (PR Newswire)
09:00AM	Actym Therapeutics Appoints Thomas Smart as CEO (PR Newswire)
Mar-28-24 04:05PM	Precigen and Recurrent Respiratory Papillomatosis Foundation to Hold Inaugural International RRP Awareness Day on June 11th (PR Newswire)
Mar-27-24 08:20AM	Analysts on Wall Street Lower Ratings for These 10 Stocks (Insider Monkey)
Mar-20-24 10:07AM	Precigen, Inc. (NASDAQ:PGEN) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-19-24 08:53PM	PGEN Stock Earnings: Precigen Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace)
05:31PM	Precigen Inc (PGEN) Reports Full Year 2023 Financial Results (GuruFocus.com)
04:05PM	Precigen Reports Full Year 2023 Financial Results and Business Updates (PR Newswire)
Mar-12-24 04:05PM	Precigen to Participate in a Fireside Chat Hosted by Cantor Fitzgerald to Discuss PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Recurrent Respiratory Papillomatosis (PR Newswire)
Mar-05-24 04:05PM	Precigen to Announce Fourth Quarter and Full Year 2023 Financial Results on March 19th (PR Newswire)
Feb-06-24 04:05PM	Precigen to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference (PR Newswire)
Jan-16-24 08:05AM	Precigen Receives Orphan Drug Designation for PRGN-2012 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission (PR Newswire)
Jan-08-24 08:30AM	Precigen Highlights Pipeline Updates to be Presented at the 42nd Annual J.P. Morgan Healthcare Conference (PR Newswire) +8.53%
Jan-02-24 12:40PM	Hedge Fund and Insider Trading News: David Einhorn, Bill Ackman, D. E. Shaw, Steve Cohen, Rob Citrone, Saba Capital, HighPeak Energy, Inc (HPK), Precigen Inc (PGEN), and More (Insider Monkey) +5.22%
Dec-18-23 04:05PM	Precigen to Present at the 42nd Annual J.P. Morgan Healthcare Conference (PR Newswire) -5.74%
Nov-29-23 04:05PM	Precigen to Participate in the JMP Securities Hematology and Oncology Summit (PR Newswire)
Nov-09-23 04:55PM	Precigen Reports Third Quarter 2023 Financial Results and Progress of Clinical Programs (PR Newswire) -13.49%

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Executive ChairmanMr. Randal J. Kirk J.D.

Ph.D.Dr. Helen Sabzevari MPH

Chief Financial OfficerMr. Harry Thomasian Jr.

Chief Operating OfficerMr. Rutul R. Shah

Ph.D.Mr. Donald P. Lehr J.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
KINDLER JEFFREY B	Director	Aug 26 '26	Sale	7.44	185,000	1,376,400	17,100	Aug 28 08:39 PM
Jeffrey Kindler	Director	Aug 26 '26	Proposed Sale	7.42	185,000	1,372,700		Aug 26 04:43 PM
AGEE NANCY H	Director	Aug 21 '26	Buy	7.23	3,411	24,662	309,187	Aug 25 05:30 PM
Shah Rutul R	Chief Operating Officer	Aug 21 '26	Option Exercise	2.33	34,658	80,753	499,670	Aug 25 05:27 PM
Shah Rutul R	Chief Operating Officer	Aug 25 '26	Option Exercise	2.33	15,342	35,747	484,207	Aug 25 05:27 PM
Shah Rutul R	Chief Operating Officer	Aug 21 '26	Sale	7.50	34,658	259,935	465,012	Aug 25 05:27 PM
Shah Rutul R	Chief Operating Officer	Aug 25 '26	Sale	7.50	15,342	115,065	468,865	Aug 25 05:27 PM
Tennant Phil	Chief Commercial Officer	Aug 25 '26	Option Exercise	1.61	79,166	127,457	221,158	Aug 25 05:25 PM
Tennant Phil	Chief Commercial Officer	Aug 25 '26	Sale	7.50	79,166	593,745	141,992	Aug 25 05:25 PM
Shah Rutul R	Officer	Aug 25 '26	Proposed Sale	7.50	15,342	115,065		Aug 25 02:01 PM
Tennant Phil	Officer	Aug 25 '26	Proposed Sale	7.50	79,166	593,745		Aug 25 01:53 PM
Shah Rutul R	Officer	Aug 21 '26	Proposed Sale	7.50	34,658	259,935		Aug 21 04:31 PM
Shah Rutul R	Chief Operating Officer	Aug 06 '26	Sale	6.86	32,739	224,590	465,012	Aug 07 05:04 PM
Shah Rutul R	Officer	Aug 06 '26	Proposed Sale	6.86	32,739	224,590		Aug 06 01:17 PM
Shah Rutul R	Chief Operating Officer	Aug 03 '26	Option Exercise	2.33	33,772	78,689	531,523	Aug 03 06:12 PM
Shah Rutul R	Chief Operating Officer	Aug 03 '26	Sale	6.50	33,772	219,518	497,751	Aug 03 06:12 PM
Shah Rutul R	Officer	Aug 03 '26	Proposed Sale	6.50	33,772	219,518		Aug 03 03:21 PM
Thomasian Harry Jr.	Chief Financial Officer	Jul 31 '26	Sale	6.06	100,000	606,000	254,535	Jul 31 04:26 PM
Thomasian Harry Jr.	Officer	Jul 31 '26	Proposed Sale	6.06	100,000	605,610		Jul 31 11:12 AM
Thomasian Harry Jr.	Chief Financial Officer	Jul 01 '26	Sale	5.53	171,429	948,002	354,535	Jul 01 06:22 PM
Thomasian Harry Jr.	Chief Financial Officer	Jun 29 '26	Sale	5.78	28,571	165,140	525,964	Jul 01 06:22 PM
Shah Rutul R	Chief Operating Officer	Jun 29 '26	Option Exercise	2.33	42,924	100,013	540,675	Jul 01 06:21 PM
Shah Rutul R	Chief Operating Officer	Jun 29 '26	Sale	5.85	42,924	251,105	497,751	Jul 01 06:21 PM
Sabzevari Helen	President and CEO	Jun 29 '26	Option Exercise	2.33	346,836	808,128	4,115,708	Jul 01 06:19 PM
Sabzevari Helen	President and CEO	Jun 29 '26	Sale	5.89	346,836	2,042,864	3,768,872	Jul 01 06:19 PM
Thomasian Harry Jr.	Officer	Jul 01 '26	Proposed Sale	5.53	171,429	948,544		Jul 01 12:20 PM
Sabzevari Helen	Officer	Jun 29 '26	Proposed Sale	5.90	346,836	2,044,627		Jun 29 04:14 PM
Shah Rutul R	Officer	Jun 29 '26	Proposed Sale	5.85	42,924	251,105		Jun 29 11:30 AM
Thomasian Harry Jr.	Officer	Jun 29 '26	Proposed Sale	5.78	28,571	165,197		Jun 29 10:58 AM
Thomasian Harry Jr.	Chief Financial Officer	May 28 '26	Sale	4.36	41,884	182,614	554,535	Jun 01 04:29 PM
Tennant Phil	Chief Commercial Officer	May 28 '26	Sale	4.36	30,272	131,986	139,369	Jun 01 04:28 PM
Shah Rutul R	Chief Operating Officer	May 28 '26	Sale	4.36	42,703	186,185	497,751	Jun 01 04:27 PM
Lehr Donald P.	Chief Legal Officer	May 28 '26	Sale	4.36	29,131	127,011	755,461	Jun 01 04:26 PM
Sabzevari Helen	President and CEO	May 28 '26	Sale	4.36	119,250	519,930	3,768,872	Jun 01 04:25 PM
KIRK RANDAL J	Director	Mar 30 '26	Sale	3.30	4,772,781	15,750,177	302,213	Mar 31 04:10 PM
Randal J. Kirk	Director	Mar 30 '26	Proposed Sale	3.67	4,772,781	17,516,106		Mar 30 05:33 PM
KIRK RANDAL J	Director	Mar 13 '26	Option Exercise	0.00	143,678	0	81,781,816	Mar 16 05:29 PM
KIRK RANDAL J	Director	Dec 22 '25	Sale	4.18	1,900,036	7,942,150	341,189	Dec 22 08:48 PM
Randal J. Kirk	Director	Dec 22 '25	Proposed Sale	4.32	1,900,036	8,208,156		Dec 22 08:19 PM
KINDLER JEFFREY B	Director	Dec 12 '25	Sale	3.63	235,467	855,899	110,603	Dec 16 04:16 PM
Jeffrey Kindler	Director	Dec 12 '25	Proposed Sale	3.69	235,467	868,873		Dec 12 06:27 PM
KIRK RANDAL J	Director	Nov 19 '25	Sale	4.47	1,086,153	4,855,104	7,434,384	Nov 21 07:54 PM
KIRK RANDAL J	Director	Nov 20 '25	Sale	4.08	942,832	3,846,755	6,491,552	Nov 21 07:54 PM
KIRK RANDAL J	Director	Nov 21 '25	Sale	3.83	937,308	3,589,890	5,554,244	Nov 21 07:54 PM
KIRK RANDAL J	Director	Nov 20 '25	Proposed Sale	4.08	942,832	3,843,885		Nov 20 05:33 PM
KIRK RANDAL J	Director	Nov 19 '25	Proposed Sale	4.22	1,086,153	4,583,565		Nov 19 05:23 PM
KINDLER JEFFREY B	Director	Sep 30 '25	Sale	3.38	106,837	361,109	346,070	Oct 01 05:16 PM
KINDLER JEFFREY B	Director	Sep 29 '25	Sale	3.60	67,523	243,083	452,907	Oct 01 05:16 PM
KIRK RANDAL J	Director	Sep 30 '25	Sale	3.41	1,809,667	6,170,964	14,597,161	Sep 30 05:44 PM
KIRK RANDAL J	Director	Sep 30 '25	Proposed Sale	3.63	1,809,667	6,569,091		Sep 30 05:26 PM
Jeffrey Kindler	Director	Sep 30 '25	Proposed Sale	3.29	106,837	351,494		Sep 30 04:21 PM
Shah Rutul R	Chief Operating Officer	Sep 26 '25	Buy	3.40	2,000	6,800	405,959	Sep 30 04:07 PM
Tennant Phil	Chief Commercial Officer	Sep 29 '25	Buy	3.58	6,000	21,480	65,031	Sep 30 04:04 PM
Jeffrey Kindler	Director	Sep 29 '25	Proposed Sale	3.63	67,523	245,108		Sep 29 04:12 PM
Thomasian Harry Jr.	Chief Financial Officer	Sep 25 '25	Buy	3.62	8,284	29,988	465,694	Sep 26 05:01 PM
Thomasian Harry Jr.	Chief Financial Officer	Sep 26 '25	Buy	3.42	2,932	10,027	468,626	Sep 26 05:01 PM
KIRK RANDAL J	Director	Sep 19 '25	Sale	3.68	3,596,892	13,236,563	8,520,537	Sep 19 08:46 PM
KIRK RANDAL J	Director	Sep 18 '25	Sale	3.86	1,403,360	5,416,970	12,117,429	Sep 19 08:46 PM
KIRK RANDAL J	Director	Sep 19 '25	Proposed Sale	3.85	252	970		Sep 19 04:47 PM
KIRK RANDAL J	Director	Sep 18 '25	Proposed Sale	3.92	5,000,000	19,625,000		Sep 18 01:30 PM
AGEE NANCY H	Director	Sep 04 '25	Buy	4.60	15,000	69,000	217,841	Sep 05 05:46 PM

AUB Atlantic Union Bankshares Corp daily Stock Chart

Peers: ZION BPOP CFR ONB SSB BOKF CBSH FNB HOMB UMBF

| Held by: IJR VTI IWM VB VBR VXF KRE IWN SPSM IJS

Index	RUT
Market Cap	5.85B
Enterprise Value	-
Income	475.42M
Sales	2.22B
Book/sh	36.31
Cash/sh	-
Dividend Est.	1.49 (3.64%)
Dividend TTM	1.48 (3.61%)
Dividend Ex-Date	Aug 07, 2026
Dividend Gr. 3/5Y	6.21% 6.81%
Payout	68.56%
Employees	3064
IPO	Oct 06, 1993

P/E	12.25
Forward P/E	10.15
PEG	0.79
P/S	2.64
P/B	1.13
P/C	-
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	-
Current Ratio	0.07
Debt/Eq	0.39
LT Debt/Eq	0.17
Option/Short	Yes / Yes

EPS (ttm)	3.34
EPS next Y	4.03
EPS next Q	0.96
EPS this Y	9.48%
EPS next Y	7.10%
EPS next 5Y	12.82%
EPS past 3/5Y	-11.96% 0.94%
Sales past 3/5Y	38.40% 21.54%
EPS Y/Y TTM	61.65%
Sales Y/Y TTM	35.21%
EPS Q/Q	835.55%
Sales Q/Q	-2.50%
Earnings	Jul 21 BMO
EPS/Sales Surpr.	2.29% -0.38%

Insider Own	1.00%
Insider Trans	0.05%
Inst Own	87.09%
Inst Trans	0.76%
ROA	1.29%
ROE	9.76%
ROIC	8.06%
Gross Margin	-
Oper. Margin	31.55%
Profit Margin	21.44%
SMA20	-0.97%
SMA50	-2.34%
SMA200	6.73%
Trades

Shs Outstand	141.92M
Shs Float	141.39M
Short Float	4.95%
Short Ratio	6.36
Short Interest	7.00M
52W High	43.62 -6.12%
52W Low	30.87 32.65%
Volatility	2.10% 1.80%
ATR (14)	0.78
RSI (14)	46.96
Beta	0.78
Rel Volume	0.00
Avg Volume	1.10M
Volume	1

Perf Week	0.30%
Perf Month	-4.81%
Perf Quarter	8.45%
Perf Half Y	12.01%
Perf YTD	16.01%
Perf Year	15.13%
Perf 3Y	34.53%
Perf 5Y	13.15%
Perf 10Y	47.62%
Recom	1.67
Target Price	47.00
Prev Close	40.60
Price	40.95
Change %	0.86%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-05-25	Downgrade	Raymond James	Strong Buy → Mkt Perform
Oct-08-25	Initiated	Janney	Buy
Sep-25-25	Initiated	TD Cowen	Buy	$46
Jun-10-25	Upgrade	Raymond James	Outperform → Strong Buy	$41
May-21-25	Initiated	Jefferies	Buy	$37
Mar-17-25	Reiterated	Hovde Group	Outperform	$46 → $40
Jan-27-25	Reiterated	Hovde Group	Outperform	$47 → $46
Jan-13-25	Resumed	Piper Sandler	Overweight	$51
Sep-13-24	Reiterated	Hovde Group	Outperform	$46 → $45
Jul-26-24	Reiterated	Hovde Group	Outperform	$40 → $46
Sep-13-23	Initiated	Stephens	Overweight	$36
Apr-06-23	Downgrade	Keefe Bruyette	Outperform → Mkt Perform	$42 → $36
Mar-03-23	Resumed	Raymond James	Outperform	$43
Dec-05-22	Resumed	Piper Sandler	Overweight	$42
Nov-29-22	Initiated	Hovde Group	Outperform	$41
Apr-22-22	Upgrade	Keefe Bruyette	Mkt Perform → Outperform
Dec-16-21	Upgrade	Piper Sandler	Neutral → Overweight	$41 → $42
Feb-18-21	Initiated	Seaport Global Securities	Buy
Jul-27-20	Resumed	Piper Sandler	Neutral
May-05-20	Upgrade	Stephens	Equal-Weight → Overweight

Show Previous Ratings

Jul-23-26 04:01PM	Atlantic Union Bankshares Corporation Declares Quarterly Common Stock Dividend and Preferred Stock Dividend (Business Wire)
Jul-22-26 08:30AM	Atlantic Union Bankshares Corporation Q2 2026 Earnings Call Summary (Moby)
Jul-21-26 07:30AM	Atlantic Union Bankshares tops second-quarter forecasts as revenue and profit increase (AUB) (InvestorsHub)
06:45AM	Atlantic Union: Q2 Earnings Snapshot (Associated Press)
06:30AM	Atlantic Union Bankshares Reports Second Quarter Financial Results (Business Wire)
07:29AM	Loading…
Jun-30-26 07:29AM	Atlantic Union Bankshares Corporation To Release Second Quarter 2026 Financial Results (Business Wire)
Jun-04-26 06:59AM	Atlantic Union Bankshares Corporation to Attend Morgan Stanley US Financials Conference (Business Wire)
Jun-03-26 06:59AM	Atlantic Union Bank Announces Planned Retirement of Doug Woolley (Business Wire)
May-05-26 04:01PM	Atlantic Union Bankshares Corporation Declares Quarterly Common Stock Dividend and Preferred Stock Dividend (Business Wire)
04:01PM	Atlantic Union Bankshares Corporation Announces $250 million Share Repurchase Program (Business Wire)
Apr-22-26 03:02AM	Atlantic Union Bankshares Corp (AUB) Q1 2026 Earnings Call Highlights: Strong Loan Growth and ... (GuruFocus.com)
Apr-21-26 04:43PM	Atlantic Union Bankshares Corporation Q1 2026 Earnings Call Summary (Moby)
06:53AM	Atlantic Union: Q1 Earnings Snapshot (Associated Press)
06:45AM	Atlantic Union Bankshares Reports First Quarter Financial Results (Business Wire)
Mar-31-26 06:55AM	Atlantic Union Bankshares Corporation To Release First Quarter 2026 Financial Results (Business Wire)
02:27PM	Loading…
Mar-10-26 02:27PM	Are Options Traders Betting on a Big Move in AUB Stock? (Zacks)
Mar-09-26 09:55AM	Atlantic Union (AUB) Could Find a Support Soon, Here's Why You Should Buy the Stock Now (Zacks)
Mar-05-26 03:28PM	Morgan Stanley Raises its Price Target on Atlantic Union Bankshares Corporation (AUB) to $47 and Maintains an Equal Weight Rating (Insider Monkey)
Mar-02-26 09:40AM	Are Finance Stocks Lagging Atlantic Union Bankshares (AUB) This Year? (Zacks)
Feb-27-26 04:40PM	Atlantic Union Bankshares, East West Bank, Coastal Financial, Wintrust Financial, and United Community Banks Shares Plummet, What You Need To Know (StockStory) -6.20%
Feb-26-26 06:45AM	Atlantic Union Bankshares Corporation to Present at Raymond James 47th Annual Institutional Investors Conference (Business Wire)
Feb-25-26 11:45AM	Atlantic Union (AUB) Could Be a Great Choice (Zacks)
Feb-24-26 06:55AM	Atlantic Union Bankshares Corporation Names Alexander D. Dodd Chief Financial Officer and Updates Transition Plan (Business Wire)
Feb-23-26 09:10AM	How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks (Zacks)
Feb-16-26 09:10AM	3 Top Dividend Stocks to Maximize Your Retirement Income (Zacks)
09:05AM	What Makes Atlantic Union Bankshares Corporation (AUB) a High-Quality Bank Stock? (Insider Monkey)
Feb-15-26 11:01PM	3 Reasons to Sell AUB and 1 Stock to Buy Instead (StockStory)
Feb-09-26 11:45AM	Are You Looking for a High-Growth Dividend Stock? (Zacks)
09:10AM	3 Top Dividend Stocks to Maximize Your Retirement Income (Zacks)
Feb-06-26 09:15AM	Orange County Bancorp, Inc. (OBT) Hits Fresh High: Is There Still Room to Run? (Zacks)
12:00PM	Loading…
Feb-04-26 12:00PM	Atlantic Union (AUB) Moves to Buy: Rationale Behind the Upgrade (Zacks)
Feb-02-26 09:10AM	3 Top Dividend Stocks to Maximize Your Retirement Income (Zacks)
Jan-29-26 04:01PM	Atlantic Union Bankshares Corporation Declares Quarterly Common Stock Dividend and Preferred Stock Dividend (Business Wire)
12:38AM	The 5 Most Interesting Analyst Questions From Atlantic Union Bankshares's Q4 Earnings Call (StockStory)
Jan-23-26 11:45AM	Atlantic Union (AUB) Could Be a Great Choice (Zacks)
12:31AM	AUB Q4 Deep Dive: Sandy Spring Integration and Core Loan Growth Shape 2025 Finish (StockStory)
Jan-22-26 04:02PM	Atlantic Union Bankshares Corp (AUB) Q4 2025 Earnings Call Highlights: Strong Loan Growth and ... (GuruFocus.com)
09:30AM	Atlantic Union (AUB) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
07:45AM	Atlantic Union (AUB) Q4 Earnings and Revenues Top Estimates (Zacks)
07:06AM	Atlantic Union Bankshares (NYSE:AUB) Beats Q4 CY2025 Sales Expectations (StockStory)
06:43AM	Atlantic Union: Q4 Earnings Snapshot (Associated Press Finance)
06:30AM	Atlantic Union Bankshares Reports Fourth Quarter and Full Year Financial Results (Business Wire)
Jan-21-26 05:34AM	Atlantic Union Bankshares (AUB) Q4 Earnings: What To Expect (StockStory) +7.04%
Jan-20-26 10:04PM	What To Expect From Atlantic Union Bankshares's (AUB) Q4 Earnings (StockStory)
Jan-16-26 10:00AM	Meridian Bank (MRBK) to Report Q4 Results: Wall Street Expects Earnings Growth (Zacks)
09:15AM	Countdown to Atlantic Union (AUB) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS (Zacks)
Jan-15-26 10:00AM	Atlantic Union (AUB) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
08:05AM	This Regional Bank Offers Rare Trifecta Of Growth, Value and Yield (Investor's Business Daily)
Jan-12-26 09:49AM	SolaREIT Expands Revolving Credit Facility to $80 Million with Atlantic Union Bank and EagleBank (PR Newswire)
Jan-11-26 11:40PM	1 Bank Stock for Long-Term Investors and 2 Facing Challenges (StockStory)
06:00AM	2 regional bank stocks to own amid rising M&A activity (Yahoo Finance Video)
Jan-07-26 04:50PM	Banking: M&A activity will see 'very rapid' boost in 2026 (Yahoo Finance Video)
Jan-04-26 10:37PM	Winners And Losers Of Q3: Atlantic Union Bankshares (NYSE:AUB) Vs The Rest Of The Regional Banks Stocks (StockStory)
Dec-30-25 08:00AM	Atlantic Union Bankshares Corporation To Release Fourth Quarter and Full Year 2025 Financial Results (Business Wire)
Dec-09-25 11:38AM	NYSE Content Advisory: Market Update + Target Opens Newly Transformed 'Target SoHo' in New York (PR Newswire)
Nov-24-25 09:10AM	3 Top Dividend Stocks to Maximize Your Retirement Income (Zacks)
Nov-21-25 06:00PM	Atlantic Union Bankshares and Ameris Bancorp Stocks Trade Up, What You Need To Know (StockStory)
Nov-19-25 01:26PM	Is the Options Market Predicting a Spike in AUB Stock? (Zacks)
08:00AM	Atlantic Union Bankshares Corporation to Host Investor Day (Business Wire)
Nov-06-25 11:03PM	3 Reasons AUB is Risky and 1 Stock to Buy Instead (StockStory)
Oct-30-25 04:01PM	Atlantic Union Bankshares Corporation Declares Quarterly Common Stock Dividend and Preferred Stock Dividend (Business Wire)
01:35AM	The Top 5 Analyst Questions From Atlantic Union Bankshares's Q3 Earnings Call (StockStory)
Oct-24-25 09:55AM	AUB Q3 Deep Dive: Sandy Spring Integration and Margin Pressures Shape Results (StockStory)
Oct-23-25 03:11PM	Atlantic Union Bankshares Corp (AUB) Q3 2025 Earnings Call Highlights: Navigating Growth Amid ... (GuruFocus.com)
09:30AM	Compared to Estimates, Atlantic Union (AUB) Q3 Earnings: A Look at Key Metrics (Zacks)
08:25AM	Atlantic Union Bankshares (NYSE:AUB) Posts Q3 Sales In Line With Estimates (StockStory)
07:55AM	Atlantic Union (AUB) Q3 Earnings and Revenues Lag Estimates (Zacks)
06:50AM	Atlantic Union: Q3 Earnings Snapshot (Associated Press Finance)
06:45AM	Atlantic Union Bankshares Reports Third Quarter Financial Results (Business Wire)
Oct-22-25 09:26AM	Atlantic Union Bankshares Corp (AUB) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
08:45AM	Middlefield Banc Corp. (MBCN) Q3 Earnings and Revenues Top Estimates (Zacks)
Oct-21-25 11:01PM	What To Expect From Atlantic Union Bankshares's (AUB) Q3 Earnings (StockStory)
Oct-16-25 10:00AM	Atlantic Union (AUB) Earnings Expected to Grow: Should You Buy? (Zacks) -5.89%
Oct-15-25 11:45AM	Are You Looking for a High-Growth Dividend Stock? (Zacks)
Oct-14-25 12:51PM	Atlantic Union Bank Completes Integration of Sandy Spring Bank (Business Wire)
07:25AM	FB Financial (FBK) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
Oct-01-25 08:00AM	Atlantic Union Bankshares Corporation To Release Third Quarter 2025 Financial Results (Business Wire)
Sep-29-25 11:45AM	Why Atlantic Union (AUB) is a Great Dividend Stock Right Now (Zacks)
Sep-18-25 05:40PM	Atlantic Union Bankshares (AUB) Stock Is Up, What You Need To Know (StockStory)
Aug-25-25 12:00AM	3 Reasons to Sell AUB and 1 Stock to Buy Instead (StockStory)
Aug-10-25 11:32PM	A Look Back at Regional Banks Stocks' Q2 Earnings: Atlantic Union Bankshares (NYSE:AUB) Vs The Rest Of The Pack (StockStory)
Jul-25-25 07:03AM	Atlantic Union: Q2 Earnings Snapshot (Associated Press Finance)
Jul-24-25 04:01PM	Atlantic Union Bankshares Corporation Declares Quarterly Common Stock Dividend and Preferred Stock Dividend (Business Wire)
08:05AM	Atlantic Union (AUB) Tops Q2 Earnings and Revenue Estimates (Zacks)
06:57AM	Atlantic Union Bankshares (NYSE:AUB) Surprises With Strong Q2 (StockStory)
06:50AM	Atlantic Union Bankshares Reports Second Quarter Financial Results (Business Wire)
Jul-23-25 09:33AM	What To Expect From Atlantic Union Bankshares Corp (AUB) Q2 2025 Earnings (GuruFocus.com)
Jul-22-25 11:01PM	Atlantic Union Bankshares (AUB) Reports Q2: Everything You Need To Know Ahead Of Earnings (StockStory)
Jul-21-25 10:00AM	Analysts Estimate Merchants Bancorp (MBIN) to Report a Decline in Earnings: What to Look Out for (Zacks)
08:15AM	HBT Financial (HBT) Tops Q2 Earnings Estimates (Zacks)
Jul-17-25 10:00AM	Atlantic Union (AUB) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
12:00AM	Atlantic Union Bankshares (AUB): Buy, Sell, or Hold Post Q1 Earnings? (StockStory)
Jul-12-25 12:00PM	Blackstone Gobbles Up Another $2 Billion In Commercial Real Estate Loans (Benzinga)
Jul-02-25 06:59AM	Atlantic Union Bankshares Corporation To Release Second Quarter 2025 Financial Results (Business Wire)
Jun-27-25 02:26PM	Atlantic Union sells $2B CRE portfolio to Blackstone unit (American Banker)
Jun-26-25 04:57PM	Blackstone deepens CRE bet with $2 billion loan purchase from Atlantic Union (Reuters)
04:45PM	Atlantic Union Bank Closes Sale of Approximately $2 Billion of Commercial Real Estate Loans to Blackstone (Business Wire)
04:01PM	Blackstone Buys Another $2 Billion in Discounted Commercial Real-Estate Loans (The Wall Street Journal)
Jun-25-25 12:04AM	3 Reasons to Sell AUB and 1 Stock to Buy Instead (StockStory)
Jun-24-25 02:18AM	AUB Q1 Deep Dive: Loan Loss Reserve Build and Sandy Spring Acquisition Shape Results (StockStory)

Atlantic Union Bankshares Corp. is a bank holding company, which engages in the provision of financial services. It specializes in offering community banking services. Its services include checking, savings, lending, credit cards, online and mobile banking, treasury management, business eBanking, and wealth management. The company was founded in July 1993 and is headquartered in Glen Allen, VA.

PresidentMr. John C. Asbury

Executive VP & Senior Financial AdvisorMr. Robert Michael Gorman

Executive Vice PresidentMr. David V. Ring

Executive Vice PresidentMs. Maria P. Tedesco

Executive Vice PresidentMr. Matthew L. Linderman

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
AGEE NANCY H	Director	Apr 20 '26	Buy	39.05	650	25,382	37,797	Apr 22 04:33 PM

PGEN

Precigen Inc

AUB

Atlantic Union Bankshares Corp

Upgrade your Finviz experience